Edition:
United Kingdom

Shop Apotheke Europe NV (SAEG.DE)

SAEG.DE on Xetra

28.95EUR
16 Aug 2019
Change (% chg)

€-0.05 (-0.17%)
Prev Close
€29.00
Open
€29.10
Day's High
€29.75
Day's Low
€28.30
Volume
28,540
Avg. Vol
18,608
52-wk High
€54.00
52-wk Low
€28.30

Latest Key Developments (Source: Significant Developments)

Shop Apotheke Europe H1 Revenues Up 32% To EUR 338 Million
Tuesday, 9 Jul 2019 

July 9 (Reuters) - Shop Apotheke Europe NV ::DGAP-NEWS: SHOP APOTHEKE EUROPE N.V. CONTINUES ITS GROWTH COURSE DURING THE FIRST HALF OF 2019; CONSOLIDATED REVENUES INCREASE BY 32% TO EUR 338 MILLION..NUMBER OF ACTIVE CUSTOMERS INCREASES BY 50% TO 4.2 MILLION..H1 REVENUES FOR DACH-SEGMENT GROW BY +27% TO EUR 298 MILLION..GUIDANCE FOR 2019 FISCAL YEAR CONFIRMED.H1 INTERNATIONAL REVENUES RISE BY +83% TO EUR 40 MILLION..  Full Article

Shop Apotheke Europe Says Break-Even Is Expected In 2020
Wednesday, 15 May 2019 

May 15 (Reuters) - Shop Apotheke Europe NV ::DGAP-NEWS: SHOP APOTHEKE EUROPE REPORTS SALES GROWTH OF 33% IN THE FIRST QUARTER OF 2019..Q1 NUMBER OF ORDERS ROSE BY 55% COMPARED TO CORRESPONDING PERIOD LAST YEAR, REACHING 3.1 MILLION (Q1 2018: 2.1 MILLION).CONSOLIDATED Q1 REVENUES ROSE BY 33% TO EUR 174.7 MILLION.Q1 CONSOLIDATED GROSS EARNINGS BY 42%, FROM EUR 23.0 MILLION DURING FIRST THREE MONTHS OF 2018 TO EUR 32.6 MILLION.OUTLOOK 2019: EXPECTS SHOP APOTHEKE EUROPE TO ACCELERATE ITS ORGANIC GROWTH RATE TO APPROXIMATELY 30% (2018: 25%).PLANNED (ADJUSTED) EBITDA MARGIN IS PROJECTED TO BE AT LEVEL OF PREVIOUS YEAR OR SLIGHTLY BETTER..BREAK-EVEN IS EXPECTED IN 2020..OUTLOOK 2019: SHOP APOTHEKE EUROPE TO INCREASE CONSOLIDATED REVENUES TO CA. EUR 700 MILLION.  Full Article

Shop Apotheke Europe Completes EUR 50 Mln Capital Increase
Wednesday, 10 Apr 2019 

April 10 (Reuters) - SHOP APOTHEKE EUROPE NV ::SUCCESSFULLY COMPLETES C. EUR 50M CAPITAL INCREASE BY PLACING 1.39M NEW BEARER SHARES AND A EUR 60M CONCURRENT TAP OF ITS EXISTING CONVERTIBLE BONDS DUE APRIL 2023 WITH INSTITUTIONAL INVESTORS..NEW SHARES ISSUE PRICE: EUR 36.00.NEW BONDS ISSUE PRICE AT 99.47%, PLUS ACCRUED INTEREST OF 2.2253% OF PAR.NET PROCEEDS TO FUND CONTINUOUS GROWTH STRATEGY.  Full Article

Shop Apotheke Europe 9-Month Consolidated Gross Earnings Up At EUR 71.8 Mln
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - SHOP APOTHEKE EUROPE NV ::INCREASES CONSOLIDATED REVENUES BY +103% TO OVER EUR 388 MILLION FOR THE FIRST NINE MONTHS OF 2018..INCREASES CONSOLIDATED REVENUES BY +103% TO OVER EUR 388 MILLION FOR FIRST NINE MONTHS OF 2018.9-MONTH CONSOLIDATED GROSS EARNINGS INCREASE BY 77% TO EUR 71.8 MILLION.9-MONTH ADJUSTED CONSOLIDATED SEGMENT EBITDA FROM EUR -1.0 MILLION TO EUR +4.8 MILLION.ON TRACK TO MEET ITS FY RECENTLY INCREASED REVENUE PROJECTION (FROM EUR 540 MILLION TO EUR 570 MILLION).EXPECTS AN ADJUSTED EBITDA MARGIN OF UP TO -2% FOR 2018 FISCAL YEAR (PREVIOUS FORECAST: -0.5%).  Full Article

Shop Apotheke Europe Revised forecast for financial year 2018
Tuesday, 13 Nov 2018 

Nov 13 (Reuters) - Shop Apotheke Europe NV ::DGAP-ADHOC: SHOP APOTHEKE EUROPE: REVISED FORECAST FOR FINANCIAL YEAR 2018.MANAGEMENT BOARD IS CONFIDENT TO ACHIEVE RECENTLY INCREASED SALES FORECAST OF EUR 540 MILLION TO EUR 570 MILLION FOR FY.SEES FY 2018 ADJUSTED EBITDA MARGIN IS EXPECTED TO BE UP TO -2%.  Full Article

Shop Apotheke Europe Says Stefan Feltens Will Succeed Michael Köhler As Chair Of The Managing Board
Monday, 17 Sep 2018 

Sept 17 (Reuters) - Shop Apotheke Europe NV ::DGAP-ADHOC: SHOP APOTHEKE EUROPE N.V.: STEFAN FELTENS TO STRENGTHEN MANAGEMENT TEAM WITH IMMEDIATE EFFECT; WILL SUCCEED MICHAEL KÖHLER, WHO WILL RESIGN AS CHAIR OF THE MANAGING BOARD FOR PERSONAL REASONS AS OF 31 DECEMBER 2018..SHOP APOTHEKE EUROPE-STEFAN FELTENS AS MANAGER OF PURCHASING AND HUMAN RESOURCES WITH IMMEDIATE EFFECT AND AS CEO AS OF 1 JAN 2019.  Full Article

Shop Apotheke Europe Sees 2018 Revenues Between EUR 540-570 Mln
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Shop Apotheke Europe NV ::DGAP-NEWS: HALF-YEAR REVENUES MORE THAN DOUBLED: SHOP APOTHEKE EUROPE CONTINUES ACCELERATED GROWTH COURSE..H1 INTERNATIONAL REVENUES ROSE BY 60% TO EUR 55 MILLION.CONSOLIDATED REVENUES ROSE BY 103% TO EUR 257.2 MILLION DURING FIRST HALF OF YEAR..H1 CONSOLIDATED GROSS EARNINGS INCREASED BY 71% TO EUR 46.4 MILLION.EXPECTS REVENUES BETWEEN EUR 540 MILLION TO EUR 570 MILLION FOR 2018.NOW FORECASTS REVENUES OF EUR 540 MILLION TO EUR 570 MILLION FOR 2018 FISCAL YEAR.GOAL IS TO ACHIEVE A BREAKEVEN CONSOLIDATED EBITDA BEFORE ONE-TIME COSTS.  Full Article

Shop Apotheke Europe Sees 2018 Revenue Between EUR 530-560 Mln
Thursday, 26 Apr 2018 

April 26 (Reuters) - Shop Apotheke Europe NV ::SEES INCREASE IN GROUP REVENUES OF 87% TO 97% TO EUR 530 M TO 560 M.SEES ALSO POSITIVE EBITDA (BEFORE ONE-OFF COSTS) AT GROUP LEVEL OF EUR 0 TO 2 M IN 2018.MANAGEMENT BOARD REVIEWED FY 2017 AND GAVE A POSITIVE OUTLOOK FOR FINANCIAL YEAR 2018.  Full Article

Shop Apotheke Europe: German Coalition Parties Intend To Plead For Ban Of RX Mail Order
Thursday, 8 Feb 2018 

Feb 8 (Reuters) - SHOP APOTHEKE EUROPE NV ::DGAP-NEWS: SHOP APOTHEKE EUROPE N.V.: GERMAN COALITION PARTIES INTEND TO PLEAD FOR BAN OF RX MAIL ORDER..SAID ON WEDNESDAY WILL TAKE ALL NECESSARY STEPS IN THE INTEREST OF ITS PATIENTS IN GERMANY TO MAINTAIN AND FURTHER BUILD ITS MAIL-ORDER BUSINESS WITH PRESCRIPTION MEDICATIONS.  Full Article

Shop Apotheke Europe 9-month EBIT loss widens to 11 million euros
Monday, 13 Nov 2017 

Nov 13 (Reuters) - SHOP APOTHEKE EUROPE NV ::INCREASES CONSOLIDATED REVENUES BY 53% AND CONFIRMS RAISED GUIDANCE.9-MONTH ‍CONSOLIDATED REVENUES UP BY +53% TO OVER EUR 191M​.9-MONTH ‍EBIT AMOUNTED TO EUR -11.0M (PREVIOUS YEAR: EUR -7.1M OR EUR -6.6M ADJUSTED)​.9-MONTH ‍GROUP'S GROSS PROFIT GROWS BY 59% TO EUR 41M, GROSS MARGIN IMPROVED TO 21.2%​.OUTLOOK 2017: ‍INCREASED REVENUE GROWTH GUIDANCE OF 55% TO 65% CONFIRMED​.  Full Article

German stocks - Factors to watch on August 14

BERLIN/FRANKFURT, Aug 14 The following are some of the factors that may move German stocks on Wednesday: